Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 Biomarker disease BEFREE Our results suggest that SLC22A18 may act as a tumor suppressor by regulating the expression levels of cell growth-related proteins, and vinca alkaloids might show therapeutic efficacy against low-SLC22A18-expressing breast cancer. 30145211 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 AlteredExpression disease BEFREE The results of Kaplan-Meier analysis indicated that SLC22A18 expression was associated with relapse-free survival (RFS) of breast cancer. 21144813 2011
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 Biomarker disease BEFREE Gain of imprinting of SLC22A18 sense and antisense transcripts in human breast cancer. 16624517 2006
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 AlteredExpression disease BEFREE HET/SAF-B protein and mRNA were detected at varying levels in all of the eight breast cancer cell lines examined. 10999774 2000
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 GeneticVariation disease BEFREE Because this region frequently is altered in neoplasms and in the genetic disease Beckwith-Wiedemann syndrome, we carried out a mutational analysis in tumor cell lines and Beckwith-Wiedemann syndrome samples that resulted in the identification of genetic alterations in the BWR1A gene: an insertion that introduced a stop codon in the breast cancer cell line BT549 and a point mutation in the rhabdomyosarcoma cell line TE125-T. 9520460 1998
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 Biomarker disease BEFREE We were able to show that HET is localized in the nuclear matrix in various breast cancer cell lines. 9328833 1997
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 Biomarker disease CTD_human
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.460 Biomarker disease HPO